Treatment of Malignant Melanoma
Treatment of Malignant Melanoma
- A 46-year-old Caucasian female presented one year ago with deep ulcerated primary tumor and multiple involved lymph nodes.
- She was diagnosed with stage IIIC melanoma.
- Patient underwent wide local incision and compete lymph node dissection and appeared to be clear of disease.
- Patient decided not to pursue adjuvant therapy after surgery.
- Six months after surgery, she developed abdominal pain.
- Imaging showed multiple masses in the liver, > 1 cm, scattered pulmonary nodules and some enlarged lymph nodes.
- Tumor biopsy confirmed melanoma and mutational analysis showed BRAF V600E mutation.
- The patient is started on dabrafenib 150 mg bid and trametinib 2 mg qd.
Recent Videos
Related Content
Atlas Examines Tolerability of Hedgehog Pathway Inhibitors and Transition to IO in mBCC
October 16th 2024Article
During a Case-Based Roundtable® event, Jennifer L. Atlas, MD, discussed treatment for a patient with basal cell carcinoma who reported challenging adverse events with hedgehog pathway inhibitor.
Read More
RELATIVITY-047 vs CheckMate 067 Matched Cohorts in Melanoma Show Similar Efficacy
October 10th 2024Article
During a Case-Based Roundtable® event, Ahmad Tarhini, MD, PhD, discussed the indirect comparison of ipilimumab plus nivolumab and nivolumab/relatlimab in advanced melanoma in the second article of a 2-part series.
Read More
